Dr. Scott S. Kaatz, DO

Dr. Kaatz practices at Henry Ford Hospital in Detroit, Michigan, part of Henry Ford Health.

Dr. Kaatz's NPI, 1376611814, was assigned on December 1, 2006. Dr. Kaatz holds Michigan license BK2777007.

Dr. Kaatz's primary practice is Henry Ford Hospital, at 2799 W Grand Blvd, Detroit, MI 48202 in Wayne County. The practice phone is (313) 916-2600.

Dr. Kaatz's primary practice is Henry Ford Hospital in Detroit, Michigan, part of Henry Ford Health. Dr. Kaatz is also affiliated with Henry Ford Macomb Hospital. The medical group on file is Henry Ford Health. Dmand AI also links Dr. Kaatz to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kaatz practices, 2 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Kaatz's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dr. Kaatz is licensed in Michigan.

CMS data shows 284 Medicare services from Dr. Kaatz across 7 procedure codes in 2024, for 148 Medicare patients. Medicare paid $22,370 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 148 Medicare patients who saw Dr. Kaatz in 2024. The largest group is 65 to 74, with 50 patients. 75% of them have high blood pressure, and 71% have high cholesterol. 48% are also on Medicaid. Their average risk score is 2.70, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kaatz's median patient age at 70, with 54% women.

In 2024, Dr. Kaatz wrote 166 Medicare Part D claims for 77 patients. 82% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $86 in total drug cost. In 2023, CMS named 176 claims across 11 drugs.

Dr. Kaatz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kaatz as offering telehealth.

Dmand AI links 133 papers to Dr. Kaatz, published from 2008 to 2025. 2022 was the busiest year, with 13. The most frequent topics are Anticoagulants, Venous Thromboembolism and Warfarin. Dr. Kaatz has published most often in J Thromb Haemost. Dr. Kaatz's most frequent co-authors are Geoffrey Douglas Barnes, MD, James B. Froehlich, MD and Jay H. Kozlowski, FACC, MD.

CMS Open Payments shows 449 general payments to Dr. Kaatz from 21 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 45% of the total. Janssen Pharmaceuticals, Inc paid the most, $165,751. It also lists 9 research payments totaling $2,000 in 2024, naming 1 clinical trial.